← All stocks

CorMedix Inc.

CRMD Net selling
CIK 0001410098 #2892 in the set updated 20 Sep 2026
Bought (12 mo)
$275.50K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$2.64M
$68.80K on a plan · $1.76M straight out of an exercise
Sold at will
$817.80K
2 of 8 sales
Net
−$2.37M
−$542.30K against sales at will

By person

13 insiders · 11 transactions
7.7×

Joseph Todisco holds 7.7 times base salary in stock. $5.33M of shares against $684.35K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Todisco last reported holding, valued at $6.88, the price Common Stock was last bought or sold at on the open market here, on 21 Jan 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dillione Janet
Director
$1.55M (5) scheduled
−$1.55M
117,835
0.1512%
$810.70K
+120.4%
Lefkowitz Steven W
Director
$475.20K (1)
−$475.20K
125,951
0.1616%
$866.54K
+66.8%
Todisco Joseph
Chief Executive Officer
$360.00K (1) scheduled
−$360.00K
774,749
0.9940%
$5.33M
+137.8%
Kaplan Myron
Director
$275.50K (1)
+$275.50K
231,487
0.2970%
$1.59M
+53.3%
DUNTON ALAN W
Director
$260.00K (1) scheduled
−$260.00K
70,703
0.0907%
$486.44K
+363.6%
Hurlburt Elizabeth
Chief Operating Officer
270,463
0.3470%
$1.86M
+631.5%
Zelnick Kaufman Beth
Chief Legal Officer
260,684
0.3344%
$1.79M
+810.8%
Seckler Michael David
Chief Commercial Officer
133,156
0.1708%
$916.11K
Blum Susan
Chief Financial Officer
124,315
0.1595%
$855.29K
Mistry Erin
EVP, Chief Commercial Officer
100,992
0.1296%
$694.82K
+99.9%
David Matthew T
Chief Financial Officer
95,270
0.1222%
$655.46K
+98.8%
Duncan Gregory Scott
Director
68,786
0.0883%
$473.25K
Stewart Robert A
Director
66,453
0.0853%
$457.20K
+504.1%
Insider
Date
Role
Action
Shares
Price
Amount
Todisco Joseph
16 Jan 2026
Chief Executive Officer
Exercised, kept
29,585
$3.38
$100.00K
Lefkowitz Steven W
12 Jan 2026
Director
Exercised, kept
15,000
$5.63
$84.45K

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 5
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,329,768
History held since 5 Oct 2016